Month: April 2023
-
Invention for Recombination with insertion-modified nucleic acid
Invented by Phillip A. Patten, Volker Heinrichs, Willem P. C. Stemmer, Codexis Mayflower Holdings LLC Recombination with insertion-modified nucleic acid (RIMNA) is a relatively new technology that has the potential to revolutionize the field of genetic engineering. RIMNA allows for the precise insertion of DNA sequences into specific locations in the genome, which can be…
-
Invention for Array cytometry
Invented by Michael Seul, Alice Xiang Li, Bioarray Solutions Ltd Array cytometry is a rapidly growing field in the healthcare industry. It is a technique that allows for the simultaneous analysis of multiple cells or molecules in a single sample. This technology has revolutionized the way we study cells and has led to many breakthroughs…
-
Invention for Array cytometry
Invented by Michael Seul, Alice X. Li, Bioarray Solutions Ltd Array cytometry is a rapidly growing field in the medical and biotechnology industries. It is a technology that allows for the simultaneous analysis of multiple biological parameters in a single sample. This technology has revolutionized the way medical professionals and researchers study cells and their…
-
Invention for Methods and kits for the preparation of multicomponent nucleic acids constructs
Invented by Peter D. Harney, deceased, Vector Objects LLC The market for methods and kits for the preparation of multicomponent nucleic acids constructs has been growing rapidly in recent years. This is due to the increasing demand for more efficient and accurate methods of gene editing and gene therapy. Multicomponent nucleic acids constructs are complex…
-
An In-Depth Look at IP Due Diligence
IP due diligence is a fundamental element in corporate transactions involving intellectual property. It offers companies an opportunity to restructure transactions, revive stagnant negotiations, and reconcile valuations. IP due diligence involves an assessment of the scope, ownership status, strength, and economic value of intellectual property assets. This may be done prior to or during a…
-
Invention for Polynucleotides that encode antibodies against sclerostin, and their uses
Invented by Michaela Kniessel, Christine Halleux, Shou-Ih Hu, Beate Diefenbach-Streiber, Josef Prassler, MORPHYSYS AG, Mereo Biopharma 3 Ltd Polynucleotides that encode antibodies against sclerostin are becoming increasingly popular in the biopharmaceutical industry. Sclerostin is a protein that is primarily produced by osteocytes, which are cells that are responsible for bone formation and maintenance. Sclerostin inhibits…
-
Invention for Non-human mammal for the production chimeric antibodies
Invented by Larry Green, Hiroaki Shizuya, Ablexis LLC The market for non-human mammals for the production of chimeric antibodies is a rapidly growing industry. Chimeric antibodies are a type of monoclonal antibody that is created by combining the variable regions of a human antibody with the constant regions of an animal antibody. This process allows…
-
Invention for Blood-brain barrier antibodies
Invented by Eric V. Shusta, Angela R Jones, Charles C. Stutz, Wisconsin Alumni Research Foundation The blood-brain barrier (BBB) is a highly selective membrane that separates the circulating blood from the brain’s extracellular fluid. It is a critical component of the central nervous system, as it protects the brain from harmful substances while allowing essential…
-
Invention for Fc variants with modified binding to FcRn
Invented by Aaron Keith CHAMBERLAIN, Bassil Dahiyat, John R. Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Xencor Inc The market for Fc variants with modified binding to FcRn is rapidly growing due to their potential therapeutic benefits. FcRn is a receptor that plays a crucial role in the recycling and transport of immunoglobulin G (IgG)…
-
Invention for Cell-derived virus vaccines with low residual cell DNA
Invented by Jens-Peter Gregersen, Holger Kost, Seqirus UK Ltd The market for cell-derived virus vaccines with low residual cell DNA is rapidly growing due to the increasing demand for safe and effective vaccines. Cell-derived virus vaccines are produced using cell cultures, which are grown in bioreactors and then infected with the virus of interest. The…